logo

Slide Shows

Share
Events

Biotech Stocks Facing FDA Decision In December 2021 Just when everyone thought that the worst of the Covid-19 pandemic may be behind us, the emergence of Omicron, a new coronavirus variant, is causing global concern. Detected first in South Africa earlier this month, Omicron cases have now been reported in at least 15 countries.

Biotech Stocks Facing FDA Decision In November 2021 Let's take a look at the biotech stocks facing FDA decision in November.

Biotech Stocks Facing FDA Decision In October 2021 The FDA has approved 39 novel drugs so far this year compared to 40 during the same period last year. A total of 53 novel drugs were approved in 2020. Let’s take a look at the biotech stocks facing FDA decision in October.

Biotech Stocks Facing FDA Decision In September 2021 As August draws to a close, let us take a look back at some of the regulatory headlines from that eventful month and look forward to what September has in store.